Sunscreen

Our Position

While a small select group have raised concerns about certain sunscreen ingredients, banning or restricting common UV filters could negatively impact public health. Sunscreen use is recommended by the Centers for Disease Control and Prevention, World Health Organization, American Academy of Dermatology, and other experts as part of a comprehensive sun protection strategy. Limiting sunscreen options could discourage daily use, leading to increased sunburn, photoaging, and skin cancer risk. Currently, no studies directly link FDA-approved sunscreen active ingredients like avobenzone, oxybenzone, and octinoxate to human health harms when used properly.

Read More

Browse Sunscreen Content

woman in hat running at sunset

Press Releases and Statements

Statement from the Consumer Healthcare Products Association Regarding Hawaii Sunscreen

Overwhelming scientific evidence shows that excess sun exposure without sunscreen increases the risk of developing skin cancer. Banning key ingredients in effective sunscreens will unnecessarily reduce the selection of safe and effective sunscreen products available.

May 3, 2018

Colleagues Examining Data on a computer

Submission

Comments to FDA: OTC Sunscreens Safety and Effectiveness Data

Comments regarding guidance for industry pertaining to sunscreen ingredients requesting inclusion into the OTC sunscreen monograph.

Feb 22, 2016

Biking into the Sunset

Submission

Comments to FDA: Sunscreen Innovation Act

Enclosed herein are comments on "Guidance for Industry; Sunscreen Innovation Act: Section 586C(c) Advisory Committee Process."

Jan 19, 2016

Orange CHPA logo on dark blue background

Submission

Comments to FDA: SIA, Withdrawal of a 586A Request or Pending Request

Enclosed herein are comments on "Guidance for Industry; Sunscreen Innovation Act: Withdrawal of a 586A Request or Pending Request", published as Draft Guidance.

Jan 19, 2016

Colleagues Examining Data on a computer

Submission

Comments to FDA: Sunscreen Drug Products - Content and Format of Data Submissions

Enclosed herein are comments on "Guidance for Industry; Nonprescription Sunscreen Drug Products - Content and Format of Data Submissions to Support a GRASE determination Under the Sunscreen Innovation Act."

Jan 19, 2016

orange bottle of sunscreen

Submission

Comments to FDA: Sunscreen Feedback Letters

We ask that in its review of the Proposed Orders, FDA take our framework into consideration when making its GRASE determinations.

Feb 23, 2015

Orange CHPA logo on dark blue background

Submission

Comments to FDA: ANPR Sunscreen Drug Products for OTC Human Use

The following comments address 1) data and information on sunscreen spray dosage forms to confirm their eligibility for inclusion in the final sunscreen monograph and 2) data and information supporting the inclusion of powder sunscreens in the final monograph.

Oct 17, 2011

Orange CHPA logo on dark blue background

Submission

Comments to FDA: Effectiveness Determination, Sunscreen Drug Products

We support the Agency's proposed decision to allow sunscreen products to be labeled with SPFs up to SPF 50+ and understand that higher SPF levels may be considered if supporting data are submitted to the Agency for review.

Sep 15, 2011

Orange CHPA logo on dark blue background

Submission

Comments to FDA: Enforcement Policy for OTC Sunscreen Drug Products Marketed Without an Approved Application

Comments submitted by the Consumer Healthcare Products Association and the Personal Care Products Council regarding draft guidance for industry on enforcement policy for OTC sunscreen drug products marketed without an approved application.

Aug 16, 2011

Female Scientist wearing goggles

Submission

Comments to FDA: SPF Labeling and Testing Requirements and Labeling for OTC Sunscreens

Personal Care Products Council and CHPA comments in response to FDA rule regarding labeling and effectiveness requirements for certain OTC sunscreen products.

Aug 16, 2011

Filter Results